Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC.
Nakatsukasa K, Niikura N, Kashiwabara K, Amemiya T, Watanabe KI, Hata H, Kikawa Y, Taniike N, Yamanaka T, Mitsunaga S, Nakagami K, Adachi M, Kondo N, Shibuya Y, Hayashi N, Naito M, Yamashita T, Umeda M, Mukai H, Ota Y.
Nakatsukasa K, et al. Among authors: taniike n.
BMC Cancer. 2021 Jan 7;21(1):34. doi: 10.1186/s12885-020-07746-9.
BMC Cancer. 2021.
PMID: 33413212
Free PMC article.
Clinical Trial.